{"title":"Anti-PIT1 hypophysitis after immune checkpoint inhibitor treatment","authors":"Shin Urai, Genzo Iguchi, Yutaka Takahashi","doi":"10.1038/s41574-025-01099-8","DOIUrl":"https://doi.org/10.1038/s41574-025-01099-8","url":null,"abstract":"Anti-PIT1 hypophysitis is a form of paraneoplastic autoimmune hypophysitis. The condition is attributable to the ectopic expression of pituitary-specific positive transcription factor 1 (PIT1) in tumour tissues, which leads to autoimmunity against PIT1-positive anterior pituitary cells. In the past few years, it has been reported that anti-PIT1 hypophysitis can occur as an immune checkpoint inhibitor-related hypophysitis.","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"28 4 1","pages":""},"PeriodicalIF":40.5,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143506788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bone and muscle crosstalk in ageing and disease","authors":"Ben Kirk, Giovanni Lombardi, Gustavo Duque","doi":"10.1038/s41574-025-01088-x","DOIUrl":"https://doi.org/10.1038/s41574-025-01088-x","url":null,"abstract":"<p>Interorgan communication between bone and skeletal muscle is central to human health. A dysregulation of bone–muscle crosstalk is implicated in several age-related diseases. Ageing-associated changes in endocrine, inflammatory, nutritional and biomechanical stimuli can influence the differentiation capacity, function and survival of mesenchymal stem cells and bone-forming and muscle-forming cells. Consequently, the secretome phenotype of bone and muscle cells is altered, leading to impaired crosstalk and, ultimately, catabolism of both tissues. Adipose tissue acts as a third player in the bone–muscle interaction by secreting factors that affect bone and muscle cells. Physical exercise remains the key biological stimulus for bone–muscle crosstalk, either directly via the release of cytokines from bone, muscle or adipocytes, or indirectly through extracellular vesicles. Overall, bone–muscle crosstalk is considered an inherent process necessary to maintain the structure and function of both tissues across the life cycle. This Review summarizes the latest biomedical advances in bone–muscle crosstalk as it pertains to human ageing and disease. We also outline future research priorities to accommodate the understanding of this rapidly emerging field.</p>","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"27 1","pages":""},"PeriodicalIF":40.5,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143495379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Sexual dimorphism in pituitary neuroendocrine tumours","authors":"Shaojian Lin, Jun Li, Zhe Bao Wu","doi":"10.1038/s41574-025-01096-x","DOIUrl":"https://doi.org/10.1038/s41574-025-01096-x","url":null,"abstract":"Pituitary neuroendocrine tumours (PitNETs) exhibit notable sex-related differences, particularly in prolactinomas and corticotroph tumours. Findings from the past 5 years in other cancers suggest that interactions between sex hormones and the immune system, as well as epigenetic modifications specific to sex chromosomes, could influence sex differences in tumour development.","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"59 1 1","pages":""},"PeriodicalIF":40.5,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143495381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neutrophils might link intestinal damage to retinopathy in type 2 diabetes mellitus","authors":"Senegal Carty","doi":"10.1038/s41574-025-01094-z","DOIUrl":"10.1038/s41574-025-01094-z","url":null,"abstract":"","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"21 4","pages":"200-200"},"PeriodicalIF":31.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143477467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Engineering adipocytes for cancer treatment","authors":"Claire Greenhill","doi":"10.1038/s41574-025-01095-y","DOIUrl":"10.1038/s41574-025-01095-y","url":null,"abstract":"","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"21 4","pages":"200-200"},"PeriodicalIF":31.0,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143451491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The enduring relevance of the Randle cycle","authors":"Azariyas A. Challa","doi":"10.1038/s41574-025-01092-1","DOIUrl":"https://doi.org/10.1038/s41574-025-01092-1","url":null,"abstract":"<p>In people with diabetes mellitus, the heart is metabolically characterized by the excessive use of fatty acids and diminished oxidation of glucose. These changes are implicated in decreased cardiac efficiency, vulnerability to ischaemic insults and an increased risk of heart failure. Interestingly, these alterations have been observed even in the absence of any impairments in cardiac insulin signalling, which suggests a role for direct substrate competition — a concept that was first described by Philip Randle and colleagues in a 1963 <i>Lancet</i> paper. The principle of reciprocal substrate competition between fatty acids and glucose for ATP generation laid out in this landmark publication formed the basis for our present understanding of cardiac metabolism in physiology and in response to metabolic stress.</p><p>Randle et al. showed that provision of exogenous fatty acids to isolated heart and diaphragm preparations or the presence of increased circulating levels of nonesterified fatty acids following adipose tissue lipolysis promotes fatty acid oxidation (FAO) and inhibits glucose utilization independent of hormonal control. The authors proposed that inhibition of pyruvate dehydrogenase (PDH; the mitochondrial enzyme that catalyses the conversion of pyruvate to acetyl-CoA) by acetyl-CoA derived from FAO is the primary mechanism by which fatty acids inhibit glucose utilization. By contrast, when glucose is abundant, utilization of glucose in adipose tissue inhibits lipolysis and the release of nonesterified fatty acids, which results in reduced fatty acid utilization by oxidative tissues and hence completes a ‘glucose–fatty acid cycle’ (now better known as the Randle cycle).</p>","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"24 1","pages":""},"PeriodicalIF":40.5,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143443174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The study that pioneered islet isolation techniques","authors":"Rula Bany Bakar","doi":"10.1038/s41574-025-01093-0","DOIUrl":"https://doi.org/10.1038/s41574-025-01093-0","url":null,"abstract":"<p>In rodents, the endocrine pancreas consists of islets of Langerhans scattered throughout the exocrine acinar tissue and accounts for a minor fraction of the organ’s total volume. This anatomical configuration, combined with the small size of the islets and the fact that they are embedded within enzyme-rich exocrine tissue, has historically made isolating intact and functional islets a considerable challenge, particularly for metabolic studies that require pure islet tissue.</p><p>Early efforts in the 1960s used free-hand microdissection to isolate small numbers of islets from rodent pancreas tissue and primarily targeted hypertrophic islets in obese rodents, in which surface islets are fairly accessible. Another method involved inducing pancreatic atrophy by ligating one of the main pancreatic ducts to facilitate islet dissection. However, these techniques were associated with notable pathological conditions, such as spontaneous hyperglycaemia in animals with hypertrophic islets and fibrosis or atrophy of the pancreas following duct ligation. Although these techniques provided foundational insights, their limited scalability and the pathological states associated with them highlighted the need for more advanced methods to reliably isolate intact islets.</p>","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"26 1","pages":""},"PeriodicalIF":40.5,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Henrik Falhammar, Svetlana Lajic, Anna Nordenström
{"title":"Recent advances in treatments for congenital adrenal hyperplasia","authors":"Henrik Falhammar, Svetlana Lajic, Anna Nordenström","doi":"10.1038/s41574-025-01089-w","DOIUrl":"10.1038/s41574-025-01089-w","url":null,"abstract":"The first CRFR1 antagonist (crinecerfont) to be used for the treatment of congenital adrenal hyperplasia recently received FDA approval. This Clinical Outlook discusses the latest phase III studies in children and adults, as well as how crinecerfont — in combination with glucocorticoid replacement — might change clinical practice and affect long-term co-morbidities.","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"21 4","pages":"197-198"},"PeriodicalIF":31.0,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143385471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}